A postmenopausal woman presents with blood-stained discharge. Her BP is 170/100 mm Hg. What is the next best step?

Explanation

## Correct Answer: C. PV exam, Pap smear, TVUSG Postmenopausal bleeding (PMB) is a red flag symptom requiring systematic evaluation regardless of comorbidities. The presence of elevated BP (170/100 mm Hg) is incidental and does not change the gynecological management priority. The discriminating principle: **any postmenopausal bleeding must be investigated to exclude malignancy** (endometrial cancer, cervical cancer, or vaginal pathology). The standard diagnostic algorithm in Indian practice (per FOGSI guidelines and DC Dutta) mandates: (1) **PV examination** to assess for cervical lesions, polyps, or atrophic changes; (2) **Pap smear** to screen for cervical dysplasia/malignancy; (3) **TVUSG** (transvaginal ultrasound) to measure endometrial thickness and assess for focal lesions. An endometrial thickness >4 mm in a postmenopausal woman warrants endometrial biopsy. This three-step approach is cost-effective, non-invasive, and diagnostic in >90% of cases in Indian settings. The elevated BP, while requiring eventual management, is secondary and does not supersede the need for gynecological evaluation. Delaying investigation risks missing early-stage malignancy when prognosis is best. ## Why the other options are wrong **A. Refer to cardiologist** — This is wrong because the elevated BP is an incidental finding and does not take priority over investigating postmenopausal bleeding. Cardiology referral for hypertension management can occur in parallel, but the gynecological emergency—excluding malignancy—must be addressed first. NBE trap: conflating comorbid hypertension with the primary presenting complaint. **B. Wait and watch** — This is wrong because postmenopausal bleeding is never a 'wait and watch' diagnosis in Indian clinical practice. Watchful waiting risks missing endometrial or cervical cancer at an early, curable stage. Per DC Dutta and FOGSI, all PMB requires prompt investigation. NBE trap: testing whether students understand that PMB is a malignancy-until-proven-otherwise scenario. **D. Reassure** — This is wrong because reassurance without investigation is inappropriate and potentially dangerous. Postmenopausal bleeding has a 10–15% risk of malignancy in Indian populations; reassurance alone delays diagnosis. The patient requires objective evaluation (PV exam, cytology, imaging) before any reassurance can be offered. NBE trap: testing whether students conflate benign causes (atrophy) with diagnostic certainty. ## High-Yield Facts - **Postmenopausal bleeding** is defined as any vaginal bleeding ≥12 months after last menstrual period and is malignancy until proven otherwise. - **Endometrial thickness >4 mm** on TVUSG in a postmenopausal woman with bleeding warrants endometrial biopsy; <4 mm is reassuring. - **PV exam + Pap smear + TVUSG** is the standard three-step diagnostic algorithm in Indian gynecology (FOGSI, DC Dutta) for PMB evaluation. - **Cervical cancer** remains the leading gynecological malignancy in India; Pap smear is essential in PMB workup even if endometrial pathology is suspected. - **Atrophic vaginitis** is the most common benign cause of PMB in India, but diagnosis is clinical and requires exclusion of malignancy first. ## Mnemonics **PMB Workup: PEC** **P**V exam → **E**ndometrial assessment (TVUSG) → **C**ytology (Pap smear). This sequence ensures direct visualization, imaging, and cytological screening in one systematic approach. **Red Flag Rule** **Any postmenopausal bleeding = Investigate first, reassure later.** Comorbidities (HTN, DM) do not change this priority; malignancy exclusion comes before management of other conditions. ## NBE Trap NBE pairs elevated BP with postmenopausal bleeding to test whether students prioritize the incidental finding (hypertension) over the primary presenting complaint (PMB). The trap is cardiology referral (option A), which diverts attention from the gynecological emergency. ## Clinical Pearl In Indian outpatient gynecology, a postmenopausal woman with blood-stained discharge is assumed to have endometrial or cervical malignancy until proven otherwise. Even if she has hypertension or other comorbidities, the first visit must include PV exam, Pap smear, and TVUSG—these can be done in the same clinic visit and guide further management (biopsy, oncology referral, or reassurance). _Reference: DC Dutta's Textbook of Gynaecology (7th ed.), Ch. 10 (Postmenopausal Bleeding); FOGSI Clinical Practice Guidelines on Abnormal Uterine Bleeding_